Abstract: Force sensing assemblies for an infusion pump are provided. A force sensing assembly includes a processor and an occlusion sensor coupled to the processor. The occlusion sensor is positioned opposed to an occluder valve when the platen is closed. The force sensing assembly measures one or more forces exerted on a fluid tube during a pump cycle. Infusion pump assemblies, methods of operating an infusion pump with a force sensing assembly, systems for controlling an infusion pump and an infusion device are also provided.

Abstract: A wasting station for receiving a wasted medication from a medication dispenser is provided. The wasting station includes a base and a locking mechanism. The base includes a weight sensor to measure a weight of a waste container supported by the base. The wasting station can determine, based on the measured weight, a volume of the wasted medication positioned within the waste container. The locking mechanism includes a first end coupled to the base. The locking mechanism also includes a second end coupled to the waste container when the locking mechanism is in a first position and decoupled from the waste container when the locking mechanism moves from the first position to a second position, thereby allowing for removal of the waste container.

Abstract: The present invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers or pharmaceutically acceptable salt (s) thereof as muscarinic M1 receptor positive allosteric modulators (M1 PAMs). The present invention describes the preparation, pharmaceutical composition and the use of such compounds.

Abstract: Systems and methods for providing automated inventory management of medicine and healthcare items stored within bins in care facilities are disclosed. A method includes providing an interactive storage device for attaching to a bin, and outputting, via an audiovisual element, a visual representation of a local inventory of the bin, receiving a user input, determining a change to the local inventory according to the user input, updating the local inventory in a non-volatile data store according to the change, synchronizing the local inventory with one or more nodes via a communication interface, and receiving, from the one or more nodes via the communication interface, periodic updates for a local cache comprising locations and inventories of one or more remote bins.

Abstract: Systems and methods for providing automated inventory management of medicine and healthcare items stored within bins in care facilities are disclosed. A method includes providing an interactive storage device for attaching to a bin, and outputting, via an audiovisual element, a visual representation of a local inventory of the bin, receiving a user input, determining a change to the local inventory according to the user input, updating the local inventory in a non-volatile data store according to the change, synchronizing the local inventory with one or more nodes via a communication interface, and receiving, from the one or more nodes via the communication interface, periodic updates for a local cache comprising locations and inventories of one or more remote bins.

Abstract: A method for remotely witnessing a medical workflow is provided. The method includes authenticating a clinician at a witnessing device. The method also includes receiving, at the witnessing device, a request to perform a medical workflow. The method further includes determining, at the witnessing device and based at least in part on the medical workflow, that a witness is required to observe the medical workflow. The method also includes initiating, at a witnessing client remotely coupled with the witnessing device, a witnessing session, wherein the witnessing client allows a witness to remotely observe the medical workflow. The method also includes enabling, in response to at least the initiation of the witnessing session, completion of the medical workflow. Related systems and articles of manufacture, including apparatuses and computer program products, are also disclosed.

Abstract: Secure medication storage is described herein. A smart latch includes an actuator, a communication interface, a display, and a processor. The actuator is configured to open and close a latch to secure a door of the enclosure. The processor can be configured to receive a user credential for accessing the enclosure, validate the user credential for accessing the enclosure, trigger the actuator to open the latch, thereby allowing the door to be opened, and trigger the actuator to close the latch after detecting that the door is closed, thereby securing the door.

Abstract: A bin assembly, bin identification system and method are disclosed. A container bin assembly includes a bin body, a latching mechanism, and controller. A method includes receiving, via a communication interface, an authenticated request to access the smart container, actuating an electromechanical latch to disengage a fastening hook, thereby initiating a mechanical movement of an access component to make an internal compartment accessible, outputting, via an audiovisual element, an alert to identify the container, confirming that the electromechanical latch has re-engaged with the fastening hook, thereby securing the internal compartment, determining a change in a local inventory, and updating the local inventory in a non-volatile data store according to the change.

Abstract: The disclosed systems and methods provide a smart container or bin. A container bin assembly includes a bin body, a latching mechanism, and controller. A method includes receiving, via a communication interface, an authenticated request to access the smart container, actuating an electromechanical latch to disengage a fastening hook, thereby initiating a mechanical movement of an access component to make an internal compartment accessible, outputting, via an audiovisual element, an alert to identify the container, confirming that the electromechanical latch has re-engaged with the fastening hook, thereby securing the internal compartment, determining a change in a local inventory, and updating the local inventory in a non-volatile data store according to the change.

Abstract: Features relating to a wasting station that provides for secure collection, anonymous auditing, and safe disposal of medication are provided. The wasting station securely receives and stores wasted medication for later analysis. The wasting system may provide for waste containers that may include electronic tags, biomarkers, and/or reagents that may be used to analyze waste items. The wasting system may include support for witnessing the wasting process, either locally or remotely.

Abstract: Secure medication storage is described herein. A smart latch includes an actuator, a communication interface, a display, and a processor. The actuator is configured to open and close a latch to secure a door of the enclosure. The processor can be configured to receive a user credential for accessing the enclosure, validate the user credential for accessing the enclosure, trigger the actuator to open the latch, thereby allowing the door to be opened, and trigger the actuator to close the latch after detecting that the door is closed, thereby securing the door.

Abstract: The disclosed systems and methods provide a smart container or bin. A container bin assembly includes a bin body, a latching mechanism, and controller. A method includes receiving, via a communication interface, an authenticated request to access the smart container, actuating an electromechanical latch to disengage a fastening hook, thereby initiating a mechanical movement of an access component to make an internal compartment accessible, outputting, via an audiovisual element, an alert to identify the container, confirming that the electromechanical latch has re-engaged with the fastening hook, thereby securing the internal compartment, determining a change in a local inventory, and updating the local inventory in a non-volatile data store according to the change.

Abstract: Systems and methods for providing automated inventory management of medicine and healthcare items stored within bins in care facilities are disclosed. A method includes providing an interactive storage device for attaching to a bin, and outputting, via an audiovisual element, a visual representation of a local inventory of the bin, receiving a user input, determining a change to the local inventory according to the user input, updating the local inventory in a non-volatile data store according to the change, synchronizing the local inventory with one or more nodes via a communication interface, and receiving, from the one or more nodes via the communication interface, periodic updates for a local cache comprising locations and inventories of one or more remote bins.

Abstract: The present invention relates to compound of formula (I), or stereoisomers and pharmaceutically acceptable salts as muscarinic M1 receptor positive allosteric modulators. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to muscarinic M1 receptor.

Abstract: A system and method of identifying a selected process point in a multi-mode pulsing process includes applying a multi-mode pulsing process to a selected wafer in a plasma process chamber, the multi-mode pulsing process including multiple cycles, each one of the cycles including at least one of multiple, different phases. At least one process output variable is collected for a selected at least one of the phases, during multiple cycles for the selected wafer. An envelope and/or a template of the collected at least one process output variable can be used to identify the selected process point. A first trajectory for the collected process output variable of a previous phase can be compared to a second trajectory of the process output variable of the selected phase. A multivariate analysis statistic of the second trajectory can be calculated and used to identify the selected process point.

Abstract: The present invention relates to compound of formula (I), or stereoisomers and pharmaceutically acceptable salts as muscarinic M1 receptor positive allosteric modulators. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to muscarinic M1 receptor.

Abstract: The present invention relates to compounds of formula (I), including their stereoisomers and pharmaceutically acceptable salts. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to 5-hydroxytryptamine 4 (5-HT4) receptor.

Abstract: The present invention relates to compounds of formula (I), including their stereoisomers and pharmaceutically acceptable salts. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to 5-hydroxytryptamine 4 (5-HT4) receptor.

Abstract: A system and method of identifying a selected process point in a multi-mode pulsing process includes applying a multi-mode pulsing process to a selected wafer in a plasma process chamber, the multi-mode pulsing process including multiple cycles, each one of the cycles including at least one of multiple, different phases. At least one process output variable is collected for a selected at least one of the phases, during multiple cycles for the selected wafer. An envelope and/or a template of the collected at least one process output variable can be used to identify the selected process point. A first trajectory for the collected process output variable of a previous phase can be compared to a second trajectory of the process output variable of the selected phase. A multivariate analysis statistic of the second trajectory can be calculated and used to identify the selected process point.

Abstract: A method for etching a tungsten containing layer in an etch chamber is provided. A substrate is placed with a tungsten containing layer in the etch chamber. A plurality of cycles is provided. Each cycle comprises a passivation phase for forming a passivation layer on sidewalls and bottoms of features in the tungsten containing layer. Additionally, each cycle comprises an etch phase for etching features in the tungsten containing layer.